Agency
Department of Health Professions
 
Board
Board of Pharmacy
 
chapter
Regulations Governing the Practice of Pharmacy [18 VAC 110 ‑ 20]
Previous Comment     Next Comment     Back to List of Comments
6/4/24  4:15 am
Commenter: Anonymous

The AKA's opposition to FDA regulation of kratom is reckless and harmful.
 

The AKA's claims about kratom's safety are contradicted by scientific evidence and numerous lawsuits. Studies have shown that kratom can cause serious health issues, including liver damage, seizures, and death, particularly when used in high doses or combined with other substances. The AKA's refusal to acknowledge these findings is a disservice to consumers and public health

CommentID: 223546